Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1463, 2004-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Oral linezolid cost saving in MRSA-related infections
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. :
Access to resources
Recommend
Ciprofloxacin stepdown programme cost saving
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 282, 2000-01 ,pp. :
Galantamine potentially cost saving for AD in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. :
Biphasic insulin aspart lifesaving and cost saving in Sweden
Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. :
Galantamine potentially cost saving for AD in Sweden
Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. :